CLVT
Clarivate Plc
NYSEUSDEQUITY
Technology
DELAYED
Strong sell
-60/100
Last price
1.47
▲ 0.02 (1.39%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.43
Prev close
1.45
Day high
1.48
Day low
1.43
Volume
3.47M
Market cap
$940.31M
P/E (TTM)
—
52W range
1.43 – 3.87
Day trading desk
Gap from prior close
-1.38%
Prior close 1.45
VWAP
1.46
+0.60% from price
Relative volume
1.48×
Normal
Session range
3.86%
1.42 – 1.48
Position in range
82%
Near session high
ATR (14D)
0.09
6.12% of price
Prior day high
1.50
PDH
Prior day low
1.43
PDL
Bid / ask spread
—
Quote not published
Session volume
7.18M
Avg 4.85M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-13.53%
-15.5%
1M
-28.99%
-30.1%
3M
-33.48%
-38.0%
6M
-39.51%
-57.7%
YTD
-55.99%
-70.2%
1Y
-62.21%
-78.6%
3Y
-78.09%
-160.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CLVT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
117.22M
Total on file
Fundamentals
Market cap$940.31M
Enterprise value$4.99B
Revenue (TTM)$2.41B
Gross profit$1.61B
EBITDA$914.80M
Net income$-334.00M
EPS (TTM)$-0.52
Free cash flow$464.64M
Total cash$206.70M
Total debt$4.26B
Book value / share$7.09
Shares outstanding639.66M
Float468.37M
Short % of float13.74%
Dividend yield0.00%
Beta (5Y)1.40
Valuation & profitability ratios
Trailing P/E—
Forward P/E2.03
PEG ratio0.18
Price / sales—
Price / book0.21
EV / revenue2.07
EV / EBITDA5.46
Gross margin66.82%
Operating margin6.13%
Profit margin-13.84%
Return on equity-7.01%
Return on assets0.94%
Debt / equity93.83
Current ratio0.85
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.46B | $2.56B | $2.63B | $2.66B | -4.0% |
| Operating revenue | $2.46B | $2.56B | $2.63B | $2.66B | -4.0% |
| Cost of revenue | $833.60M | $869.20M | $906.40M | $954.00M | -4.1% |
| Gross profit | $1.62B | $1.69B | $1.72B | $1.71B | -3.9% |
| Selling, general & admin | $708.60M | $727.60M | $739.70M | $729.90M | -2.6% |
| Total operating expense | $1.45B | $1.45B | $1.45B | $1.44B | -0.3% |
| Operating income | $172.10M | $234.20M | $274.10M | $266.30M | -26.5% |
| Net interest income | -$265.40M | -$283.40M | -$293.70M | -$270.30M | +6.4% |
| Pre-tax income | -$193.90M | -$553.80M | -$1.01B | -$3.99B | +65.0% |
| Tax provision | $7.20M | $82.90M | -$101.30M | -$28.90M | -91.3% |
| Net income | -$201.10M | -$636.70M | -$911.20M | -$3.96B | +68.4% |
| Net income to common | -$201.10M | -$668.00M | -$986.60M | -$4.04B | +69.9% |
| Basic EPS | -0.30 | -0.96 | -1.47 | -5.97 | +68.7% |
| Diluted EPS | -0.30 | -0.96 | -1.47 | -6.24 | +68.7% |
| EBIT | $71.50M | -$270.40M | -$718.80M | -$3.72B | +126.4% |
| EBITDA | $828.70M | $456.60M | -$10.50M | -$3.01B | +81.5% |
| Basic shares | 673.30M | 693.60M | 671.60M | 676.10M | -2.9% |
| Diluted shares | 673.30M | 693.60M | 671.60M | 678.60M | -2.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $329.20M | $295.20M | $370.70M | $356.80M | — | +11.5% |
| Cash & short-term investments | $329.20M | $295.20M | $370.70M | $356.80M | — | +11.5% |
| Accounts receivable | $821.70M | $798.30M | $908.30M | $872.10M | — | +2.9% |
| Total current assets | $1.31B | $1.24B | $1.46B | $1.40B | — | +5.3% |
| Property, plant & equipment | $99.30M | $107.10M | $106.80M | $113.40M | — | -7.3% |
| Goodwill & intangibles | $9.57B | $10.01B | $11.03B | $12.31B | — | -4.3% |
| Total assets | $11.07B | $11.49B | $12.71B | $13.94B | — | -3.7% |
| Total current liabilities | $1.57B | $1.43B | $1.60B | $1.56B | — | +9.4% |
| Current debt | $101.50M | $1.30M | — | $1.00M | $30.60M | +7,707.7% |
| Long-term debt | $4.32B | $4.52B | $4.72B | $5.00B | — | -4.4% |
| Total debt | $4.48B | $4.59B | $4.81B | $5.10B | — | -2.5% |
| Total liabilities | $6.23B | $6.35B | $6.71B | $7.13B | — | -2.0% |
| Retained earnings | -$7.51B | -$7.31B | -$6.65B | -$5.66B | — | -2.7% |
| Shareholder equity | $4.84B | $5.14B | $5.99B | $6.81B | — | -5.8% |
| Working capital | -$258.80M | -$188.90M | -$137.80M | -$164.60M | — | -37.0% |
| Net tangible assets | -$4.73B | -$4.87B | -$5.04B | -$5.50B | — | +2.8% |
| Shares issued | 640.70M | 691.40M | 666.10M | 674.41M | — | -7.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$201.10M | -$636.70M | -$911.20M | -$3.96B | +68.4% |
| Depreciation & amortisation | $757.20M | $727.00M | $708.30M | $710.50M | +4.2% |
| Stock-based compensation | $63.10M | $59.90M | $109.00M | $93.90M | +5.3% |
| Change in working capital | $3.50M | -$24.90M | -$60.40M | -$271.90M | +114.1% |
| Operating cash flow | $628.50M | $646.60M | $744.20M | $509.30M | -2.8% |
| Capital expenditure | -$263.20M | -$289.10M | -$242.50M | -$202.90M | +9.0% |
| Investing cash flow | -$263.20M | -$236.70M | -$237.40M | $57.30M | -11.2% |
| Share buybacks | -$224.50M | -$200.00M | -$100.00M | -$175.00M | -12.3% |
| Dividends paid | $0 | -$37.70M | -$75.50M | -$75.40M | +100.0% |
| Financing cash flow | -$343.10M | -$470.10M | -$496.50M | -$759.20M | +27.0% |
| Free cash flow | $365.30M | $357.50M | $501.70M | $306.40M | +2.2% |
| End cash position | $329.20M | $295.20M | $370.70M | $356.80M | +11.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $587.30M | $585.50M | $617.00M | $623.10M | $621.40M | +0.3% |
| Operating revenue | $587.30M | $585.50M | $617.00M | $623.10M | $621.40M | +0.3% |
| Cost of revenue | $185.50M | $192.10M | $204.80M | $218.20M | $203.60M | -3.4% |
| Gross profit | $401.80M | $393.40M | $412.20M | $404.90M | $417.80M | +2.1% |
| Selling, general & admin | $181.60M | $176.30M | $179.10M | $170.00M | $181.10M | +3.0% |
| Total operating expense | $365.80M | $363.80M | $354.20M | $364.30M | $368.90M | +0.5% |
| Operating income | $36.00M | $29.60M | $58.00M | $40.60M | $48.90M | +21.6% |
| Net interest income | -$60.40M | -$59.00M | -$66.00M | -$68.50M | -$66.60M | -2.4% |
| Pre-tax income | -$260.60M | -$28.80M | -$24.60M | -$24.50M | -$59.70M | -804.9% |
| Tax provision | $8.00M | $11.40M | -$27.70M | $3.80M | $12.30M | -29.8% |
| Net income | -$268.60M | -$40.20M | $3.10M | -$28.30M | -$72.00M | -568.2% |
| Net income to common | -$268.60M | -$40.20M | $3.10M | -$28.30M | -$72.00M | -568.2% |
| Basic EPS | -0.42 | -0.06 | 0.00 | -0.04 | -0.11 | -600.0% |
| Diluted EPS | -0.42 | -0.06 | 0.00 | -0.04 | -0.11 | -600.0% |
| EBIT | -$200.20M | $30.20M | $41.40M | $44.00M | $6.90M | -762.9% |
| EBITDA | -$14.50M | $214.20M | $230.50M | $235.80M | $197.80M | -106.8% |
| Basic shares | 639.40M | 640.70M | 654.20M | 668.30M | 681.30M | -0.2% |
| Diluted shares | 639.40M | 640.70M | 662.30M | 668.30M | 681.30M | -0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $217.70M | $232.30M | $329.20M | $318.70M | $352.30M | -6.3% |
| Cash & short-term investments | $217.70M | $232.30M | $329.20M | $318.70M | $352.30M | -6.3% |
| Accounts receivable | $827.90M | $882.90M | $821.70M | $810.70M | $820.40M | -6.2% |
| Total current assets | $1.21B | $1.30B | $1.31B | $1.29B | $1.34B | -6.7% |
| Property, plant & equipment | $88.30M | $93.40M | $99.30M | $102.60M | $109.50M | -5.5% |
| Goodwill & intangibles | $9.08B | $9.43B | $9.57B | $9.72B | $9.85B | -3.7% |
| Total assets | $10.49B | $10.93B | $11.07B | $11.23B | $11.42B | -4.0% |
| Total current liabilities | $1.44B | $1.54B | $1.57B | $1.49B | $1.48B | -6.9% |
| Current debt | $1.60M | $1.50M | $101.50M | — | — | +6.7% |
| Long-term debt | $4.21B | $4.28B | $4.32B | $4.42B | $4.52B | -1.7% |
| Total debt | $4.26B | $4.33B | $4.48B | $4.48B | $4.59B | -1.8% |
| Total liabilities | $5.95B | $6.14B | $6.23B | $6.32B | $6.43B | -3.1% |
| Retained earnings | -$7.82B | -$7.55B | -$7.51B | -$7.52B | -$7.49B | -3.6% |
| Shareholder equity | $4.54B | $4.79B | $4.84B | $4.90B | $4.99B | -5.2% |
| Working capital | -$221.50M | -$241.00M | -$258.80M | -$198.50M | -$138.60M | +8.1% |
| Net tangible assets | -$4.54B | -$4.64B | -$4.73B | -$4.81B | -$4.86B | +2.2% |
| Shares issued | 639.66M | 639.22M | 640.70M | 661.44M | 672.22M | +0.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$268.60M | -$40.20M | $3.10M | -$28.30M | -$72.00M | — | -568.2% |
| Depreciation & amortisation | $185.70M | $184.00M | $189.10M | $191.80M | $190.90M | — | +0.9% |
| Stock-based compensation | $15.20M | $14.20M | $17.70M | $16.10M | $18.60M | — | +7.0% |
| Change in working capital | -$50.10M | -$9.80M | -$26.20M | $22.20M | -$47.00M | — | -411.2% |
| Operating cash flow | $98.70M | $134.70M | $159.90M | $181.10M | $116.30M | — | -26.7% |
| Capital expenditure | -$54.70M | -$55.80M | -$70.70M | -$65.60M | -$66.00M | — | +2.0% |
| Investing cash flow | -$54.70M | -$55.80M | -$70.70M | -$65.60M | -$66.00M | — | +2.0% |
| Share buybacks | $0 | -$18.10M | -$75.00M | -$50.00M | -$49.50M | — | +100.0% |
| Dividends paid | — | — | $0 | $0 | $0 | $0 | — |
| Financing cash flow | -$68.90M | -$162.30M | -$77.90M | -$154.70M | -$53.90M | — | +57.5% |
| Free cash flow | $44.00M | $78.90M | $89.20M | $115.50M | $50.30M | — | -44.2% |
| End cash position | $217.70M | $242.20M | $329.20M | $318.70M | $362.60M | — | -10.1% |
Options analytics
Put / call volume
14.80
Put-heavy session
Put / call open interest
53.00
Positioning, not flow
Max pain
5.00
+240.1% from spot
ATM implied vol
1128.1%
Nearest strike to spot
Skew (10% OTM)
-1,128.1%
Calls bid over puts
Call volume
5
Contracts, this expiry
Put volume
74
Contracts, this expiry
Heaviest call OI
1.50
1 contracts
Heaviest put OI
5.00
52 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.18 | 0.19 | +4.9% |
| Mar 2026 | 0.14 | 0.18 | +24.8% |
| Dec 2025 | 0.16 | 0.20 | +22.2% |
| Sep 2025 | 0.16 | 0.18 | +15.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.16 | 2 | $490.10M | -21.3% |
| Next quarter | 0.18 | 2 | $506.70M | -17.9% |
| Current year | 0.71 | 2 | $2.17B | -11.6% |
| Next year | 0.72 | 2 | $2.03B | -6.5% |
Analyst targets & ownership
Mean target$2.97
High target$5.50
Low target$2.00
Implied upside101.79%
Analyst count6
ConsensusNONE
Strong buy / Buy0 / 2
Hold5
Sell / Strong sell0 / 1
Held by insiders18.33%
Held by institutions93.19%
Institutions holding325
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.65
-11.06% from price
SMA 20
1.78
-17.30% from price
SMA 50
1.91
-23.22% from price
SMA 100
2.11
-30.22% from price
SMA 200
2.37
-38.10% from price
EMA 12
1.65
-11.06% from price
EMA 26
1.78
-17.48% from price
EMA 50
1.90
-22.72% from price
RSI (14)
24.9
Oversold
MACD (12,26,9)
-0.13
Hist -0.04
ATR (14)
0.09
6.12% of price
Realised vol 30D
50.6%
Annualised
Bollinger upper
2.10
20, 2σ
Bollinger lower
1.46
20, 2σ
50 / 200 cross
Death
1.91 vs 2.37
Trend bias
Below 200
-38.10%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.90
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
50.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-61.8%
Peak to trough
Max drawdown 5Y
-94.3%
Peak to trough
ATR 14
0.09
6.12% of price
Beta (reported)
1.40
5Y monthly, from filing
Short interest
Shares short
48.44M
Prior 51.03M
Change vs prior
-5.1%
Shorts covering
% of float
13.74%
Elevated
% of shares out
7.57%
Against total outstanding
Days to cover
11.8
Crowded exit
Float
468.37M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 30, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Jul 30, 26 | Goldman Sachs | MAINTAINED | Neutral | Neutral |
| Jul 30, 26 | Stifel | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| Jul 7, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| Mar 4, 26 | Citigroup | MAINTAINED | Neutral | Neutral |
| Feb 25, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| Feb 25, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Jan 8, 26 | Goldman Sachs | DOWNGRADE | Buy | Neutral |
| Dec 17, 25 | Morgan Stanley | DOWNGRADE | Equal-Weight | Underweight |
| Sep 3, 25 | Wolfe Research | INITIATED | — | Peer Perform |
| Jul 18, 25 | Jefferies | DOWNGRADE | Buy | Hold |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay dateMar 15, 2018
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-24
Corporate Changes & Voting Matters
8-K · 2026-09-23
Corporate Changes & Voting Matters
8-K · 2026-09-17
Periodic Financial Reports
10-Q · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-07-06
Corporate Changes & Voting Matters
8-K · 2026-06-08
Corporate Changes & Voting Matters
8-K · 2026-05-18
Corporate Changes & Voting Matters
8-K · 2026-04-29
Headlines
Clarivate Completes $600 Million Sale of Life Sciences & Healthcare Segment
MT Newswires · 9h ago
Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation
PR Newswire · 9h ago
Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
PR Newswire · 13d ago
Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
PR Newswire · 13d ago
Clarivate to Report Third Quarter 2026 Results on November 3, 2026
PR Newswire · 15d ago
Clarivate Subsidiary Launches Cash Tender Offer for Senior Secured Notes
MT Newswires · 20d ago
Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities
PR Newswire · 20d ago
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
PR Newswire · 20d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.